Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Bi-Weekly Temozolomide Plus Bevacizumab for Adult Patients With Recurrent Glioblastoma Multiforme

NCT00883298 is registered in ClinicalTrials.gov with Center for Neurosciences, Tucson as lead sponsor.

NCT NCT00883298
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00883298 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Bi-Weekly Temozolomide Plus Bevacizumab for Adult Patients With Recurrent Glioblastoma Multiforme
Lead sponsor
Center for Neurosciences, Tucson
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2009
Completion date
December 1, 2014
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent glioblastoma multiforme, recurrent gliosarcoma